대장암환자의 항암화학요법 관련 인지손상과 삶의 질: 심리적 디스트레스(우울·불안)의 매개효과 = Chemotherapy-related Cognitive Impairment and Quality of Life in People with Colon Cancer: The Mediating Effect of Psychological Distress

다국어 초록 (Multilingual Abstract)

Purpose: The purpose of this study was to test the mediating effect of psychological distress in the relationship between chemotherapyrelated cognitive impairment (CRCI) and quality of life (QOL) in people with cancer. Methods: A purposive sample of 130 patients undergoingchemotherapy was recruited for the cross-sectional survey design. Data were collected from November 2014 to June 2015. Theinstruments were K-MMSE (Korean Mini-Mental State Examination), Everyday Cognition (ECog), Hospital Anxiety Depression Scale(HADS), and Functional Assessment of Cancer Therapy-General (FACT-G). Data were analyzed using descriptive statistics, correlation,and multiple regression using Baron and Kenny steps for mediation. Results: The mean score for objective cognitive function was 27.95and 69.32 for perceived cognitive decline. Overall quality of life was 91.74. The mean score was 17.52 for psychological distress. Theprevalence was 56.2% for anxiety and 63.1% for depression, and 20.0% for CRCI. There were significant correlations among the variables,objective cognitive function and self-reported cognitive decline, psychological distress, and quality of life. Psychological distresswas directly affected by CRCI. (R2=29%). QOL was directly affected by CRCI. Psychological distress and CRCI effected QOL (R2=43%).
Psychological distress had a partial mediating effect (β= -.56, p <.001) in the relationship between self-reported cognitive decline andquality of life (Sobel test: Z= -5.08, p <.001). Conclusion: Based on the findings of this study, nursing intervention programs focusing onmanaging cognitive decline, and decreasing psychological distress are highly recommended to improve quality of life in cancer patients.

참고문헌 (Reference)

1 정복례, "화학요법을 받는 유방암 환자의 인지기능장애 관련 요인" 대한종양간호학회 12 (12): 221-229, 2012

2 박진희, "유방암 환자에서 화학요법이 인지기능에 미치는 영향에 대한 메타분석" 한국간호과학회 42 (42): 644-658, 2012

3 박진희, "유방암 환자에서 화학요법관련 인지기능저하의 발생률과 발생양상" 한국간호과학회 45 (45): 118-128, 2015

4 박진희, "유방암 생존자의 신체적 증상, 정서적 증상과 삶의 질" 한국간호과학회 39 (39): 613-621, 2009

5 오복자, "암 환자에게 적용한 심리사회적 중재가 코티졸과 면역기능에 미친 효과: 메타분석" 한국간호과학회 44 (44): 446-457, 2014

6 Baron RM, "The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations" 51 (51): 1173-1182, 1986

7 Pereira J, "The frequency and clinical course of cognitive impairment in patients with terminal cancer" 79 (79): 835-842, 1997

8 Baek Y., "The correlation among symptoms, anxiety, depression and quality of life in patients with colorectal cancer undergoing chemotherapy" Seoul National University 2013

9 C. A. Meyers, "The Use of the Mini-Mental State Examination to Assess Cognitive Functioning in Cancer Trials: No Ifs, Ands, Buts, or Sensitivity" American Society of Clinical Oncology (ASCO) 21 (21): 3557-3558, 2003

10 Marleen J.J. Pullens, "Subjective cognitive dysfunction in breast cancer patients: a systematic review" Wiley-Blackwell 19 (19): 1127-1138, 2010

11 Karin Gehring, "Review of recent studies on interventions for cognitive deficits in patients with cancer" Informa Healthcare 12 (12): 255-269, 2014

12 National Cancer Information Center, "Recommendations for distress management in cancer patients, version 1.0" Ministry for Health, Welfare and Family Affairs

13 Amanda D. Hutchinson, "Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review" Elsevier BV 38 (38): 926-934, 2012

14 J S Wefel, "Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target" Springer Nature 90 (90): 1691-1696, 2004

15 Jochen Kaiser, "Neural correlates of chemotherapy-related cognitive impairment" Elsevier BV 54 : 33-50, 2014

16 Katharyn E. Hall, "Memory complaints in epilepsy: An accurate reflection of memory impairment or an indicator of poor adjustment? A Review of the literature" Elsevier BV 29 (29): 354-367, 2009

17 Michiel B. de Ruiter, "Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging" Wiley-Blackwell 33 (33): 2971-2983, 2012

18 강연욱, "K-MMSE(Korean-Mini Mental State Examination)의 노인 규준 연구" 한국심리학회 25 (25): 1-12, 2006

19 김환, "Functional Assessment Cancer Therapy-General(FACT-G)의 한국판 개발 및 타당화" 한국임상심리학회 22 (22): 215-229, 2003

20 R. S. Prabhu, "Effect of the Addition of Chemotherapy to Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma: Secondary Analysis of RTOG 98-02" American Society of Clinical Oncology (ASCO) 32 (32): 535-541, 2014

21 Massimo Pasquini, "Depression in cancer patients: A critical review" Bentham Science Publishers Ltd. 3 (3): 2-, 2007

22 Marie Lange, "Cognitive dysfunctions in elderly cancer patients: A new challenge for oncologists" Elsevier BV 40 (40): 810-817, 2014

23 Lisa M. Hess, "Chemotherapy-Related Change in Cognitive Function: A Conceptual Model" Oncology Nursing Society (ONS) 34 (34): 981-994, 2007

24 Schagen SB, "Change in cognitive function after chemotherapy: A prospective longitudinal study in breast cancer patients" 98 (98): 1742-1745, 2006

25 Gilroy J., "Basic neurology" McGraw-Hill Professional Publishing 2000

26 Nico Hutter, "Are depression and anxiety determinants or indicators of quality of life in breast cancer patients?" Informa UK Limited 18 (18): 412-419, 2013

27 Ministry of Health & Welfare, "Annual report of cancer statistics in Korea in 2012" Ministry of Health & Welfare 2014

28 Oh SM, "A study on the standardization of the hospital anxiety and depression scale for Koreans: A comparison of normal, depressed and anxious groups" 38 (38): 289-296, 1999

29 V Jenkins, "A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer" Springer Nature 94 (94): 828-834, 2006